Danske Bank’s Nutex Health NUTX Stock Holding History

Danske Bank’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$43	–	1569
2024 Q3	$43	Buy	+2	New	+$29	﹤0.01%	1480

Other funds holding NUTX

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OPOWM

One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

DWM

Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Danske Bank's NUTX Position: Q4 2024 in Review

Danske Bank sold out of Nutex Health (NUTX) in Q4 2024, closing a stake of 2 shares — an estimated $43 sold.

Danske Bank first reported a position in NUTX in Q3 2024 and held it in 1 quarter. The position peaked at $43 in Q3 2024. 41 funds tracked by Wall St. Rank hold NUTX as of Q4 2024.

Danske Bank reported no remaining Nutex Health position as of Q4 2024 after selling out during the quarter.
Danske Bank sold 2 Nutex Health shares in Q4 2024, an estimated $43.
Danske Bank first reported a position in Nutex Health in Q3 2024 and held it in 1 quarter.
Danske Bank's Nutex Health position peaked at $43 in Q3 2024.
41 funds tracked by Wall St. Rank held Nutex Health as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.